ReachMD

Be part of the knowledge.™

Oncology and Hematology

278

LikeLikedUnlike

Episodes 16-30 of 47

- Robert Mocharnuk, MD
  Peer
- Richard S. Finn, MD
  Peer
- Amit Singal, MD, MS
  Peer
8
CME/CE
Multidisciplinary Perspectives in Advanced HCC: A Focus on Immune Checkpoint Inhibitors
Multidisciplinary Perspectives in Advanced HCC: A Focus on Immune Checkpoint Inhibitors
0.75 credits
- Karen Reckamp, MS, MD
  Peer
- Heather Wakelee, MD
  Peer
5
CME/CE
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era
1.00 credits
- Karen Reckamp, MS, MD
  Peer
- Heather Wakelee, MD
  Peer
7
CME/CE
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era: A Video-based Patient Case Series
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era: A Video-based Patient Case Series
0.50 credits
- Robert Mocharnuk, MD
  Peer
- Hossein Borghaei, MS, DO
  Peer
7
CME/CE
Part II: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
Part II: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
0.50 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
6
CME/CE
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
- Josep Tabernero, MD, PhD
  Peer
8
CME/CE
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Linda R. Duska, MD, MPH
  Peer
16
CME/CE
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
0.25 credits
- Mark A. Socinski, MD
  Peer
- Alexander Drilon, MD
  Peer
11
CME/CE
Keeping Pace: Advances in RET Fusion-Positive NSCLC
Keeping Pace: Advances in RET Fusion-Positive NSCLC
0.25 credits
- Sara Hurvitz, MD
  Peer
- Jacob Sands, MD
  Peer
8
CME/CE
Clinical Considerations for Targeted Therapies Across Multiple Tumor Types
Clinical Considerations for Targeted Therapies Across Multiple Tumor Types
0.25 credits
- Mark A. Socinski, MD
  Peer
- Helena Yu, MD
  Peer
8
CME/CE
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
0.25 credits
- Jennifer Caudle, DO
  Peer
- Mikkael A. Sekeres, MD, MS
  Peer
- Sara M. Tinsley, PhD, ARNP, AOCNP
  Peer
2
CME/CE
A Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway
A Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway
0.50 credits
- Robert Mocharnuk, MD
  Peer
- Hossein Borghaei, MS, DO
  Peer
4
CME/CE
Part I: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
Part I: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
0.50 credits
- Mark A. Socinski, MD
  Peer
- Gilberto de Lima Lopes Junior, MD, MBA, FAMS
  Peer
5
CME/CE
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lung Cancer
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lung Cancer
0.25 credits
- William J. Gradishar MD, FASCO, FACP
  Peer
- Peter Schmid, FRCP, MD, PhD
  Peer
6
CME/CE
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Metastatic Breast Cancer
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Metastatic Breast Cancer
0.25 credits
- William D. Tap, MD
  Peer
- John Healey, MD
  Peer
9
CME/CE
Best Practices in the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
Best Practices in the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
0.25 credits

Loading...

Programs 3/1/21

Segment Chapters

Playlist:

Recommended